Literature DB >> 17955609

Clinical and diagnostic characterization of canal dehiscence syndrome: a great otologic mimicker.

Guangwei Zhou1, Quinton Gopen, Dennis S Poe.   

Abstract

OBJECTIVE: To identify otologic and audiologic characteristics of superior (and posterior) semicircular canal dehiscence (SCD). STUDY
DESIGN: Retrospective case review.
SETTING: Tertiary referral center. PATIENTS: Sixty-five adult patients were evaluated for SCD; 26 of 65 (35 ears) had dehiscence. INTERVENTION(S): Otologic examination, high-resolution computerized tomography (CT), air and bone audiometry, tympanometry, acoustic reflex, and vestibular evoked myogenic potential (VEMP). MAIN OUTCOME MEASURE(S): Imaging demonstrating canal dehiscence, preferentially including Poschel and Stenvers reconstructions. Audiologic findings of pseudoconductive loss, intact ipsilateral stapedial reflex, and abnormally low VEMP thresholds.
RESULTS: The most common presenting complaints were autophony of voice and a "blocked ear" (94%), mimicking patulous eustachian tube, including relief with Valsalva or supine position (50%), but without autophony of nasal breathing. Pseudoconductive loss was found in 86% of dehiscence ears, and 60% (21 of 35) of these ears had better than 0-dB-hearing-loss bone conduction thresholds at 250 and/or 500 Hz. Acoustic reflex was present in 89%. Assuming CT as the criterion standard, VEMP resulted in 91.4% sensitivity and 95.8% specificity. One false-positive CT, with abnormal VEMP, resulted in surgical explorations negative for superior SCD but positive for posterior SCD.
CONCLUSION: Semicircular canal dehiscence may present with various symptoms such as autophony, ear blockage, and dizziness/vertigo. A combination of high-resolution CT and audiologic testing is recommended for diagnosis. Low-frequency conductive loss with better than 0 dB hearing level (HL) bone conduction threshold and normal tympanometry, with intact acoustic reflexes, are audiologic signs of SCD. Vestibular evoked myogenic potential is highly sensitive and specific for SCD, possibly better than CT.

Entities:  

Mesh:

Year:  2007        PMID: 17955609

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  6 in total

1.  Toward Optimizing cVEMP: 2,000-Hz Tone Bursts Improve the Detection of Superior Canal Dehiscence.

Authors:  Kimberley S Noij; Barbara S Herrmann; John J Guinan; Steven D Rauch
Journal:  Audiol Neurootol       Date:  2019-01-24       Impact factor: 1.854

2.  Comorbidities confounding the outcomes of surgery for third window syndrome: Outlier analysis.

Authors:  P Ashley Wackym; Heather T Mackay-Promitas; Shaban Demirel; Gerard J Gianoli; Martin S Gizzi; Dale M Carter; David A Siker
Journal:  Laryngoscope Investig Otolaryngol       Date:  2017-08-22

3.  Description of a New Labyrinthine Dehiscence: Horizontal Semicircular Canal Dehiscence at the Tympanic Segment of the Facial Nerve.

Authors:  Gerard Gianoli; James Soileau; Bradley Shore
Journal:  Front Neurol       Date:  2022-06-27       Impact factor: 4.086

4.  Radiographic features of superior semicircular canal dehiscence in the setting of chronic ear disease.

Authors:  Brian C Gartrell; Lindell R Gentry; Tabassum A Kennedy; Samuel P Gubbels
Journal:  Otol Neurotol       Date:  2014-01       Impact factor: 2.311

5.  Can Wideband Tympanometry Be Used as a Screening Test for Superior Semicircular Canal Dehiscence?

Authors:  Emine Demir; Nazife Nur Afacan; Metin Celiker; Fatma Beyazal Celiker; Mehmet Fatih İnecikli; Suat Terzi; Engin Dursun
Journal:  Clin Exp Otorhinolaryngol       Date:  2018-11-22       Impact factor: 3.372

6.  Superior semicircular canal dehiscence syndrome: Diagnostic criteria consensus document of the committee for the classification of vestibular disorders of the Bárány Society.

Authors:  Bryan K Ward; Raymond van de Berg; Vincent van Rompaey; Alexandre Bisdorff; Timothy E Hullar; Miriam S Welgampola; John P Carey
Journal:  J Vestib Res       Date:  2021       Impact factor: 2.354

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.